Stellar Biotechnologies Inc Share Price Nasdaq
Equities
CA85855A2039
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.82M 1.08B |
---|---|---|---|---|---|
Net income 2024 * | -8M -625M | Net income 2025 * | -10M -781M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.96
x | P/E ratio 2025 * |
-2.46
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.93% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Michael Brooks
PSD | President | 46 | 31/08/15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 14/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 06/06/19 |
Frank Oakes
BRD | Director/Board Member | 73 | 08/04/10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 22/05/23 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |